Evidence map›Paper›PMID 42033241›Full record

ArticleGut microbes2026

An oral-gut microbial metabolite links

Yiwen Li, Qian Xu, Mengmeng Zhu, Wenting Wang, Yanfei Liu, Hongjun Yang, Yue Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yiwen LiBeijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
Qian XuNational Clinical Research Center for TCM Cardiology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Mengmeng ZhuNational Clinical Research Center for TCM Cardiology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Wenting WangDepartment of Traditional Chinese Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yanfei LiuThe Second Department of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Hongjun YangChina Academy of Chinese Medical Sciences, Beijing, China.
Yue LiuNational Clinical Research Center for TCM Cardiology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.ORCID 0000-0002-0084-863X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyocardial ischemia-reperfusion injury (MIRI) remains a major complication.

methodsAn oral

results

conclusions

Indexed as

Fusobacterium InfectionsFusobacterium nucleatumGastrointestinal MicrobiomeMyocardial Reperfusion InjuryAnimalsDisease Models, AnimalHumansImidazolesMaleMiceMice, Inbred C57BLTOR Serine-Threonine KinasesImidazolesTOR Serine-Threonine KinasesautophagyFusobacterium nucleatumimidazole propionatemyocardial ischemia–reperfusion injuryoral–gut axis

Identifiers

PMID42033241
PMCPMC13114118

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.